NCT05582551Recruiting
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
Highlighting Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
Source: ClinicalTrials.gov · Last updated 15 Jun 2026
Brief summary (registry, in English)
The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 146 (estimated)
- First submitted
- 13 Oct 2022
- Start date
- 2 Aug 2023
- Primary completion date
- 31 May 2027
- Lead sponsor
- Washington University School of Medicine
- Diseases
- Childhood cancers
- NCT number
- NCT05582551
What you commit to
- Study type: Interventional
- Planned participants: 146
- From 2 Aug 2023 to the primary completion date, 31 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening.
Other illness
- Undergoing active cancer treatment
Other
- Patient under the care of the Late Effects Program at St. Louis Children's Hospital
- Parents and/or patient illiteracy
- No contact with treatment team in the past two years
- In foster care or without a legal guardian
Who the study is looking for
- Patients with a diagnosis of pediatric cancer (diagnosis at \<18 years of age)
- Treatment including chemotherapy and/or radiation therapy
- Completion of all cancer therapy for at least 6 months and less than 2 years
- Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine
- Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group)
- English speaking
Age in the registry: 7 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| St. Louis Children's Hospital - Washington University School of Medicine Coordinator of this site? Confirm its status | St Louis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.